1. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. The Journal of allergy and clinical immunology. 2017;140(4):950-8.
2. Meltzer EO, Blaiss MS, Naclerio RM, Stoloff SW, Derebery MJ, Nelson HS, et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 2012;33 Suppl 1:S113-41.
3. Storms W. Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Primary care respiratory journal : journal of the General Practice Airways Group. 2008;17(1):7-18.
4. Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. The New England journal of medicine. 2005;353(18):1934-44.
5. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. The Journal of allergy and clinical immunology. 2008;122(2 Suppl):S1-84.
6. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62 Suppl 85:17-25.
7. Naclerio RM, Proud D, Togias AG, Adkinson NF, Jr., Meyers DA, Kagey-Sobotka A, et al. Inflammatory mediators in late antigen-induced rhinitis. The New England journal of medicine. 1985;313(2):65-70.
8. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. The Journal of allergy and clinical immunology. 1990;86(6 Pt 1):924-35.
9. Kumasaka T, Aritake K, Ago H, Irikura D, Tsurumura T, Yamamoto M, et al. Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase. The Journal of biological chemistry. 2009;284(33):22344-52.
10. Jowsey IR, Thomson AM, Flanagan JU, Murdock PR, Moore GB, Meyer DJ, et al. Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue- specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J. 2001;359(Pt 3):507-16.
11. Urade Y, Eguchi N, Aritake K, Hayaishi O. [Functional analyses of lipocalin-type and hematopoietic prostaglandin D synthases]. Nihon yakurigaku zasshi Folia pharmacologica Japonica. 2004;123(1):5-13.
12. Okano M, Fujiwara T, Sugata Y, Gotoh D, Masaoka Y, Sogo M, et al. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. American journal of rhinology. 2006;20(3):342-8.
13. Kajiwara D, Aoyagi H, Shigeno K, Togawa M, Tanaka K, Inagaki N, et al. Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of experimental allergic rhinitis. European journal of pharmacology. 2011;667(1-3):389-95.
14. Paragi-Vedanthi P, Doble M. Comparison of PGH2 binding site in prostaglandin synthases. BMC Bioinformatics. 2010;11 Suppl 1:S51.
15. Peebles RS, Jr., Dworski R, Collins RD, Jarzecka K, Mitchell DB, Graham BS, et al. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. American journal of respiratory and critical care medicine. 2000;162(2 Pt 1):676-81.
16. Takahashi G, Tanaka H, Higuchi N, Ikeda M, Inagaki N, Shichijo M. The potential role of prostaglandin D2 in nasal congestion observed in a guinea pig model of allergic rhinitis. International archives of allergy and immunology. 2012;158(4):359-68.
17. Takahashi G, Asanuma F, Suzuki N, Hattori M, Sakamoto S, Kugimiya A, et al. Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma. European journal of pharmacology. 2015;765:15-23.
18. Shiraishi Y, Takeda K, Domenico J, Gelfand EW. Role of prostaglandin D2 and CRTH2 blockade in early- and late-phase nasal responses. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2014;44(8):1076-82.
19. Mitsumori S, Tsuri T, Honma T, Hiramatsu Y, Okada T, Hashizume H, et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6- Dimethylbicyclo[3.1.1]heptane derivatives. Journal of medicinal chemistry. 2003;46(12):2446-55.
20. Armer RE, Ashton MR, Boyd EA, Brennan CJ, Brookfield FA, Gazi L, et al. Indole- 3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. Journal of medicinal chemistry. 2005;48(20):6174-7.
21. Kupczyk M, Kuna P. Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives. Drugs. 2017;77(12):1281-94.
22. Cingi C, Muluk NB, Ipci K, Sahin E. Antileukotrienes in upper airway inflammatory diseases. Current allergy and asthma reports. 2015;15(11):64.
23. Kishi Y, Nakano Y, Jiang S, Yatsuzuka R, Kamei C. Participation in cysteinyl leukotrienes and thromboxane A2 in nasal congestion model in Brown Norway rats. International immunopharmacology. 2007;7(11):1483-7.
24. Kurata Y, Yamamoto A, Izawa K, Akagi M, Kamei C. Participation of prostaglandin E2 receptor in nasal congestion of Brown Norway rats. Biological & pharmaceutical bulletin. 2010;33(1):64-6.
25. Taniguchi M, Mitsui C, Hayashi H, Ono E, Kajiwara K, Mita H, et al. Aspirin- exacerbated respiratory disease (AERD): Current understanding of AERD. Allergology international : official journal of the Japanese Society of Allergology. 2019;68(3):289-95.
26. Rahman A, Inoue T, Ago J, Ishikawa T, Kamei C. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats. European journal of pharmacology. 2007;554(2-3):229-34.
27. Lieber G, Jimenez J, Hunter JC, McLeod RL, Jia Y. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat. Pharmacology. 2010;85(5):311-8.
28. McLeod RL, Mingo GG, Xu X, Palamanda J, Hunter JC, Jia Y. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion. American journal of rhinology & allergy. 2009;23(6):e17-22.
29. Chen M, Xu S, Zhou P, He G, Jie Q, Wu Y. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades. European journal of pharmacology. 2015;767:98-107.
30. Sakairi T, Suzuki K, Makita S, Wajima T, Shakuto S, Yoshida Y, et al. Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis. Pharmacology. 2005;75(2):76-86.
31. Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA. Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow. International archives of allergy and immunology. 2004;134(1):34-40.
32. Mizutani N, Nabe T, Imai A, Sakurai H, Takenaka H, Kohno S. Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels. Japanese journal of pharmacology. 2001;86(2):170-82.
33. Mizutani N, Nabe T, Fujii M, Yoshino S, Kohno S. Involvement of peroxynitrite in pollen-induced nasal blockage in guinea pigs. European journal of pharmacology. 2008;582(1-3):139-44.
34. Yamasaki M, Mizutani N, Sasaki K, Nabe T, Matsumoto T, Ashida Y, et al. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Inflammation research : official journal of the European Histamine Research Society [et al]. 2001;50(9):466-73.
35. Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Khattiyawittayakun L, Snidvongs K. Leukotriene Receptor Antagonist Addition to H1-Antihistamine Is Effective for Treating Allergic Rhinitis: A Systematic Review and Meta-analysis. American journal of rhinology & allergy. 2019;33(5):591-600.
36. Kang JW, Lee YH, Kang MJ, Lee HJ, Oh R, Min HJ, et al. Synergistic mucus secretion by histamine and IL-4 through TMEM16A in airway epithelium. American journal of physiology Lung cellular and molecular physiology. 2017;313(3):L466-L76.
37. Choi YH, Lee SN, Aoyagi H, Yamasaki Y, Yoo JY, Park B, et al. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling. The Journal of biological chemistry. 2011;286(39):34199-214.
38. Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2003;33(10):1380-8.
39. Carson JL, Hernandez M, Jaspers I, Mills K, Brighton L, Zhou H, et al. Interleukin- 13 stimulates production of nitric oxide in cultured human nasal epithelium. In vitro cellular & developmental biology Animal. 2018;54(3):200-4.
40. Miyahara S, Miyahara N, Matsubara S, Takeda K, Koya T, Gelfand EW. IL-13 is essential to the late-phase response in allergic rhinitis. The Journal of allergy and clinical immunology. 2006;118(5):1110-6.
41. Suojalehto H, Vehmas T, Lindstrom I, Kennedy DW, Kilpelainen M, Plosila T, et al. Nasal nitric oxide is dependent on sinus obstruction in allergic rhinitis. The Laryngoscope. 2014;124(6):E213-8.
42. Aritake K, Kado Y, Inoue T, Miyano M, Urade Y. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. The Journal of biological chemistry. 2006;281(22):15277-86.